Bristol-Myers Squibb (NYSE:BMY) was upgraded from Buy to Conviction Buy at Goldman Sachs today. The stock closed yesterday at $33.13 on volume of 7.4 million shares, below average daily volume of 11.8 million. In the past 52 weeks, Bristol-Myers Squibb share prices have been bracketed by a low of $28.70 and a high of $36.34 and closed yesterday at $33.14, 15% above that low price. Over the last five market days, the 200-day moving average (MA) has remained constant while the 50-day MA has declined 0.3%.